LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 513 | 5711 | 10401 | 0.5491 | 0.5257 |
MCF 10A | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 3620 | 10401 | 0.3481 | 0.3143 |
MCF 10A | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 513 | 5692 | 10401 | 0.5473 | 0.5238 |
MCF 10A | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 513 | 9782 | 10401 | 0.9405 | 0.9374 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 3084 | 10401 | 0.2965 | 0.2600 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 513 | 371 | 10401 | 0.0357 | -0.0144 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 513 | 407 | 10401 | 0.0391 | -0.0108 |
MCF 10A | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 513 | 6006 | 10401 | 0.5775 | 0.5556 |
MCF 10A | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 683 | 10401 | 0.0657 | 0.0172 |
MCF 10A | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 10452 | 10401 | 1.0050 | 1.0052 |
MCF 10A | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 513 | 7959 | 10401 | 0.7652 | 0.7531 |
MCF 10A | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 513 | 7796 | 10401 | 0.7496 | 0.7366 |
MCF 10A | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 513 | 967 | 10401 | 0.0930 | 0.0459 |
MCF 10A | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 513 | 1472 | 10401 | 0.1415 | 0.0970 |
MCF 10A | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 513 | 3336 | 10401 | 0.3207 | 0.2855 |
MCF 10A | PD0325901 | 3.33 | uM | LJP5 | 72 | hr | 513 | 579 | 10401 | 0.0557 | 0.0067 |
MCF 10A | PD0325901 | 3.33 | uM | LJP6 | 72 | hr | 513 | 493 | 10401 | 0.0474 | -0.0021 |
MCF 10A | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 513 | 10543 | 10401 | 1.0137 | 1.0144 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1165 | 10401 | 0.1120 | 0.0659 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 680 | 10401 | 0.0654 | 0.0169 |
MCF 10A | PF431396 | 3.33 | uM | LJP5 | 72 | hr | 513 | 761 | 10401 | 0.0732 | 0.0250 |
MCF 10A | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 513 | 931 | 10401 | 0.0896 | 0.0423 |
MCF 10A | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 513 | 668 | 10401 | 0.0643 | 0.0157 |
MCF 10A | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 513 | 9651 | 10401 | 0.9279 | 0.9242 |
MCF 10A | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 513 | 511 | 10401 | 0.0492 | -0.0002 |